Last Updated: 10 Nov 2024
Executive Summary
Hamilton Lane Inc. (HLNE) is a leading investment firm specializing in fund and direct investments. The company has a strong financial performance with a market capitalization of $10.78 billion, EBITDA of $301.21 million, and EPS of $4.63. The stock is currently trading at $194.47, within its 52-week range of $87.99 to $196.6. While the stock has a high trailing PE ratio of 42.0, it is expected to decline to 38.76 forward. Analysts have a neutral outlook on the stock, with 7 rating it a hold.
Company Overview
Hamilton Lane Inc. is headquartered in Conshohocken, Pennsylvania, with additional offices worldwide. The company provides investment advisory services to institutional investors, including pension funds, endowments, foundations, and family offices. Hamilton Lane also offers direct investment opportunities in private equity, real estate, and other alternative asset classes.
Fundamental Analysis
Hamilton Lane has a strong financial position with a profit margin of 0.28 and an operating margin of 0.448. The company's return on assets and equity are also strong at 0.131 and 0.346, respectively. Revenue and earnings have grown steadily in recent quarters, with quarterly earnings growth of 0.238% and revenue growth of 0.182% year-over-year.
Technical Analysis
The stock price of HLNE has been trending upwards in recent months, breaking above its 200-day moving average. The stock is currently trading near its 52-week high, indicating strong momentum. The relative strength index (RSI) is also above 70, suggesting that the stock is overbought.
Short Term Outlook
In the short term, HLNE is expected to continue to trade within its recent range. The stock may face some resistance at its 52-week high, but it could also continue to move higher if the positive momentum continues.
Long Term Outlook
In the long term, HLNE is expected to benefit from the growing demand for alternative investments. The company's strong track record and global presence should continue to attract new clients and drive growth.
Analyst Recommendations
Analysts have a neutral outlook on HLNE. Seven analysts have a hold rating on the stock, while none have a strong buy, buy, sell, or strong sell rating. The average analyst target price is $182.17, which is below the current stock price.
